Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer.

Although assessed in two small but independent cohorts, an [F]FDG-PET radiomic signature based on the evaluation scan seems promising for the prediction of overall survival for HNSSC treated with preoperative afatinib. The robustness and clinical applicability of this radiomic signature should be assessed in a larger cohort.